• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组合混合-工艺变量方法:一种用于纳米囊泡系统优化的合适统计工具。

Combined mixture-process variable approach: a suitable statistical tool for nanovesicular systems optimization.

作者信息

Habib Basant A, AbouGhaly Mohamed H H

机构信息

a Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy , Cairo University , Cairo , Egypt.

出版信息

Expert Opin Drug Deliv. 2016 Jun;13(6):777-88. doi: 10.1517/17425247.2016.1166202. Epub 2016 Apr 4.

DOI:10.1517/17425247.2016.1166202
PMID:27020331
Abstract

OBJECTIVES

This study aims to illustrate the applicability of combined mixture-process variable (MPV) design and modeling for optimization of nanovesicular systems.

METHODS

The D-optimal experimental plan studied the influence of three mixture components (MCs) and two process variables (PVs) on lercanidipine transfersomes. The MCs were phosphatidylcholine (A), sodium glycocholate (B) and lercanidipine hydrochloride (C), while the PVs were glycerol amount in the hydration mixture (D) and sonication time (E). The studied responses were Y1: particle size, Y2: zeta potential and Y3: entrapment efficiency percent (EE%). Polynomial equations were used to study the influence of MCs and PVs on each response. Response surface methodology and multiple response optimization were applied to optimize the formulation with the goals of minimizing Y1 and maximizing Y2 and Y3.

RESULTS

The obtained polynomial models had prediction R(2) values of 0.645, 0.947 and 0.795 for Y1, Y2 and Y3, respectively. Contour, Piepel's response trace, perturbation, and interaction plots were drawn for responses representation. The optimized formulation, A: 265 mg, B: 10 mg, C: 40 mg, D: zero g and E: 120 s, had desirability of 0.9526. The actual response values for the optimized formulation were within the two-sided 95% prediction intervals and were close to the predicted values with maximum percent deviation of 6.2%.

CONCLUSIONS

This indicates the validity of combined MPV design and modeling for optimization of transfersomal formulations as an example of nanovesicular systems.

摘要

目的

本研究旨在阐明混合过程变量(MPV)设计与建模相结合在纳米囊泡系统优化中的适用性。

方法

采用D - 最优实验设计方案,研究三种混合成分(MCs)和两个过程变量(PVs)对乐卡地平传递体的影响。混合成分包括磷脂酰胆碱(A)、甘氨胆酸钠(B)和盐酸乐卡地平(C),而过程变量为水合混合物中的甘油量(D)和超声处理时间(E)。所研究的响应指标为Y1:粒径,Y2:zeta电位,Y3:包封率百分比(EE%)。使用多项式方程研究混合成分和过程变量对每个响应指标的影响。应用响应面法和多响应优化来优化制剂,目标是使Y1最小化,Y2和Y3最大化。

结果

所得到的多项式模型对Y1、Y2和Y3的预测R(2)值分别为0.645、0.947和0.795。绘制了等高线图、皮佩尔响应轨迹图、扰动图和相互作用图以表示响应情况。优化后的制剂配方为:A:265mg,B:10mg,C:40mg,D:0g,E:120s,可取性为0.9526。优化制剂的实际响应值在双侧95%预测区间内,且与预测值接近,最大偏差百分比为6.

相似文献

1
Combined mixture-process variable approach: a suitable statistical tool for nanovesicular systems optimization.组合混合-工艺变量方法:一种用于纳米囊泡系统优化的合适统计工具。
Expert Opin Drug Deliv. 2016 Jun;13(6):777-88. doi: 10.1517/17425247.2016.1166202. Epub 2016 Apr 4.
2
Enhanced transdermal delivery of ondansetron using nanovesicular systems: Fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example.采用纳米囊泡系统增强昂丹司琼经皮传递:制备、表征、优化及体外渗透研究-Box-Cox 变换实例。
Eur J Pharm Sci. 2018 Mar 30;115:352-361. doi: 10.1016/j.ejps.2018.01.044. Epub 2018 Jan 31.
3
Statistical Sequential Experimentation: Preliminary Mixed Factorial Design, I-Optimal Mixture Design Then Finally Novel Design Space Expansion for Optimization of Tazarotene Cubosomes.统计序贯实验:初步混合因子设计、I-最优混合设计,最后是用于他扎罗汀立方液晶纳米粒优化的新型设计空间扩展
Int J Nanomedicine. 2022 Mar 12;17:1069-1086. doi: 10.2147/IJN.S337130. eCollection 2022.
4
Nano-transfersomes as a novel carrier for transdermal delivery.纳米转脂体作为一种新型经皮给药载体。
Int J Pharm. 2013 Sep 15;454(1):367-80. doi: 10.1016/j.ijpharm.2013.07.031. Epub 2013 Jul 17.
5
Mixture-process variable approach to optimize a microemulsion electrokinetic chromatography method for the quality control of a nutraceutical based on coenzyme Q10.基于辅酶 Q10 的营养保健品的质量控制的微乳液电动色谱方法的混合物过程变量优化方法。
Talanta. 2012 Aug 15;97:73-82. doi: 10.1016/j.talanta.2012.03.064. Epub 2012 Apr 25.
6
Systematic Development and Optimization of an in-situ Gelling System for Moxifloxacin Ocular Nanosuspension using High-pressure Homogenization with an Improved Encapsulation Efficiency.采用高压匀质法制备莫西沙星眼用纳米混悬剂原位凝胶系统:系统的开发与优化及包封效率的改善
Curr Pharm Des. 2018;24(13):1434-1445. doi: 10.2174/1381612824666180403115106.
7
Response surface methodology for the development of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate.用于开发全反式醋酸视黄醇自纳米乳化药物递送系统(SNEDDS)的响应面法
Pharm Dev Technol. 2005;10(3):363-70. doi: 10.1081/pdt-65675.
8
Optimization of polymeric nano drug delivery system using 3(2) full factorial design.采用 3(2) 完全析因设计优化聚合物纳米药物传递系统。
Curr Drug Deliv. 2013 Aug;10(4):394-403. doi: 10.2174/1567201811310040004.
9
Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation.Box-Behnken 设计在理解染料木黄酮自微乳给药系统质量及其制剂优化中的应用。
Pharm Dev Technol. 2009;14(6):642-9. doi: 10.3109/10837450902882385.
10
Optimization of self-microemulsifying drug delivery system for telmisartan using Box-Behnken design and desirability function.采用 Box-Behnken 设计和可满意度函数优化替米沙坦自微乳给药系统。
J Pharm Pharmacol. 2013 Oct;65(10):1440-50. doi: 10.1111/jphp.12115. Epub 2013 Jul 24.

引用本文的文献

1
Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells.融合实验设计与纳米技术以开发优化的辛伐他汀长效弹性体:一种增强对多种人类癌细胞抑制作用的有前景的联合策略。
Pharmaceutics. 2022 May 9;14(5):1024. doi: 10.3390/pharmaceutics14051024.
2
Statistical Sequential Experimentation: Preliminary Mixed Factorial Design, I-Optimal Mixture Design Then Finally Novel Design Space Expansion for Optimization of Tazarotene Cubosomes.统计序贯实验:初步混合因子设计、I-最优混合设计,最后是用于他扎罗汀立方液晶纳米粒优化的新型设计空间扩展
Int J Nanomedicine. 2022 Mar 12;17:1069-1086. doi: 10.2147/IJN.S337130. eCollection 2022.
3
D-optimal mixture design for optimization of topical dapsone niosomes: in vitro characterization and in vivo activity against .D-最优混合设计优化局部氨苯砜非离子囊泡:体外特性和体内对.的活性
Drug Deliv. 2022 Dec;29(1):821-836. doi: 10.1080/10717544.2022.2048131.
4
Formulation, characterization, optimization, and performance of febuxostat self-nano-emulsifying system loaded sublingual films.载负非布司他自微乳释药系统的舌下膜的配方设计、特性描述、优化和性能评价。
Drug Deliv. 2021 Dec;28(1):1321-1333. doi: 10.1080/10717544.2021.1927247.
5
A novel transdermal nanoethosomal gel of lercanidipine HCl for treatment of hypertension: optimization using Box-Benkhen design, in vitro and in vivo characterization.盐酸乐卡地平新型透皮纳米囊凝胶治疗高血压的研究:Box-Benkhen 设计优化、体外及体内评价。
Drug Deliv Transl Res. 2020 Feb;10(1):227-240. doi: 10.1007/s13346-019-00676-5.
6
Solutol HS15 based binary mixed micelles with penetration enhancers for augmented corneal delivery of sertaconazole nitrate: optimization, in vitro, ex vivo and in vivo characterization.基于 Solutol HS15 的二元混合胶束与渗透促进剂用于增强硝酸舍他康唑的角膜递药:优化、体外、离体和体内评价。
Drug Deliv. 2018 Nov;25(1):1706-1717. doi: 10.1080/10717544.2018.1497107.
7
Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.通过前体脂质体凝胶制剂实现盐酸多佐胺的眼部持续递送:在兔体内的体外特征描述、统计优化和药效动力学评价。
Drug Deliv. 2018 Nov;25(1):1340-1349. doi: 10.1080/10717544.2018.1477861.